Wolverine Trading’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,010
| Closed | -$99.7K | – | 1808 |
|
|
2025
Q1 | $99.7K | Sell |
28,010
-13,532
| -33% | -$48.2K | ﹤0.01% | 1138 |
|
|
2024
Q4 | $298K | Sell |
41,542
-10,178
| -20% | -$73K | ﹤0.01% | 1055 |
|
|
2024
Q3 | $497K | Buy |
51,720
+17,725
| +52% | +$170K | ﹤0.01% | 671 |
|
|
2024
Q2 | $273K | Buy |
33,995
+3,544
| +12% | +$28.4K | ﹤0.01% | 903 |
|
|
2024
Q1 | $451K | Sell |
30,451
-91,676
| -75% | -$1.36M | ﹤0.01% | 665 |
|
|
2023
Q4 | $993K | Buy |
122,127
+63,265
| +107% | +$514K | ﹤0.01% | 441 |
|
|
2023
Q3 | $268K | Buy |
58,862
+2,243
| +4% | +$10.2K | ﹤0.01% | 813 |
|
|
2023
Q2 | $399K | Buy |
56,619
+23,451
| +71% | +$165K | ﹤0.01% | 598 |
|
|
2023
Q1 | $204K | Buy |
+33,168
| New | +$204K | ﹤0.01% | 804 |
|
|
2022
Q4 | – | Sell |
-16,279
| Closed | -$155K | – | 1552 |
|
|
2022
Q3 | $155K | Buy |
+16,279
| New | +$155K | ﹤0.01% | 951 |
|
|
2022
Q2 | – | Sell |
-15,912
| Closed | -$266K | – | 1754 |
|
|
2022
Q1 | $266K | Sell |
15,912
-576
| -3% | -$9.63K | ﹤0.01% | 1053 |
|
|
2021
Q4 | $320K | Sell |
16,488
-7,771
| -32% | -$151K | ﹤0.01% | 1080 |
|
|
2021
Q3 | $577K | Sell |
24,259
-4,690
| -16% | -$112K | ﹤0.01% | 922 |
|
|
2021
Q2 | $762K | Buy |
+28,949
| New | +$762K | ﹤0.01% | 755 |
|